Participants required for Short Clinical RCT following Published Research showing Neurotrophic Imaging of a Novel Extract

Are you treating patients for ADHD? Are some patients resistant to taking Ritalin?

Seeking to increase the sample size and improve the power of a Novel RCT.

Novel research published in Journal of Neurochemistry in January 2023 attracted 1.4 billion views and over $12 million in revenue.

Measuring for attention and mood in rats, Professor Frederic Meunier at The Queensland Brain Institute, is showing promising results for improved memory and focus, with potential application to Attention Deficit Disorder and other cognitive behavioural conditions.

Red shows the neurotrophic effect on the growth cone (green) in the hours following intake of Hericium erinaceus (Lions Mane).

We are seeking up to five GP SuperClinics interested in contributing to a short Clinical RCT on ADHD and other neurological conditions.

Please contact a.dennehy@uq.net.au for further information.